← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 31, 2018Last known activity
Dec 31, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT07282340CollaboratorPhase 2Dec 31, 2025
- NCT05994183Lead sponsorEarly Phase 1Oct 9, 2023
- NCT03686150Lead sponsorPhase 1Dec 31, 2018
Details
- Last known activity
- Dec 31, 2025